FDA Inspection 1276411 — C.G. Laboratories, Inc.

C.G. Laboratories, Inc. — FEI 3001451800

The FDA completed an inspection of C.G. Laboratories, Inc. on Jul 24, 2025 in Granbury, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 24, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Granbury, TX (United States)

Citations

IDCFRDescription
1232021 CFR 1271.160(b)(3)Actions verified, short and long term solutions
1233621 CFR 1271.180(a)Procedures to meet core CTGP
1244321 CFR 1271.270(d)Retention time (10 year rules)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.